(Q38359190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

NF-κB in cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Feng Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jingwen Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Frank Arfuso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Arunachalam Chinnathambi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M E Zayed

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Sulaiman Ali Alharbi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Alan Prem Kumar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Kwang Seok Ahn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

18 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

published in

Archives of Toxicology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

711-731

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00204-015-1470-4

1 March 2020

exact match

0 references

cites work

The proteasome: a suitable antineoplastic target

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB: the enemy within

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Molecular targets of dietary agents for prevention and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

21 January 2018

Pathogenesis of myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB and liver carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The NF-kappa B and I kappa B proteins: new discoveries and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

A randomized trial of aspirin to prevent colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Molecular viral oncology of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The enigmatic X gene of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IkappaB kinase alpha kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Novel IKK inhibitors: beta-carbolines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Shaping the nuclear action of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Mutations in the NF-kappaB signaling pathway: implications for human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Classical and/or alternative NF-kappaB pathway activation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IAP family proteins--suppressors of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclin D1 and human neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

5,6-Dichloro-ribifuranosylbenzimidazole- and apigenin-induced sensitization of colon cancer cells to TNF-alpha-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

LPS induction of gene expression in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Shared principles in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cellular stress response and apoptosis in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappa B as a therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The role of IL-6 and STAT3 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The inhibitors of apoptosis (IAPs) as cancer targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB in cancer: from innocent bystander to major culprit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Transcriptional activation of survivin through the NF-kappaB pathway by human T-cell leukemia virus type I tax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Endothelial cell adhesion molecules and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB: its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IAP-targeted therapies for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Protein kinase CK2 in mammary gland tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappa B is upregulated in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Dysregulated molecular networks in head and neck carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Reactive oxygen species mediate crosstalk between NF-kappaB and JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Anticancer agent CHS 828 suppresses nuclear factor-kappa B activity in cancer cells through downregulation of IKK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Linking JNK signaling to NF-kappaB: a key to survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Formation of an IKKalpha-dependent transcription complex is required for estrogen receptor-mediated gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Achieving transcriptional specificity with NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB: tumor promoter or suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Integrating cell-signalling pathways with NF-kappaB and IKK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: an ECSG/EORTC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Aberrant rel/nfkb genes and activity in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

A phase 2 study of bortezomib in relapsed, refractory myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB signaling pathway and its therapeutic implications in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor expression via activation of nuclear factor- B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Potential pharmacological control of the NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Multifaceted link between cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB: a friend or a foe in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Antitumor activity of thalidomide in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclooxygenases: structural, cellular, and molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cancer chemoprevention with dietary phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inhibition of JNK activation through NF-kappaB target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NFkappaB pathway: a good signaling paradigm and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Inflammation and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Regulation and function of NF-kappaB transcription factors in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear factor-kappaB in development, prevention, and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The proteasome and proteasome inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Signal integration by JNK and p38 MAPK pathways in cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Current and potential inflammation targeted therapies in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cross-talk between transcription factors NF-kappa B and C/EBP in the transcriptional regulation of genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Sulindac inhibits activation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Cyclooxygenases in cancer: progress and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Overexpression of phosphorylated nuclear factor-kappa B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

NF-kappaB regulates androgen receptor expression and prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Nuclear Factor- B Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Expression of NF-?B in prostate cancer lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

EGFR and Her-2 regulate the constitutive activation of NF-kappaB in PC-3 prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

Ferritin Heavy Chain Upregulation by NF-κB Inhibits TNFα-Induced Apoptosis by Suppressing Reactive Oxygen Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-015-1470-4

10.1007/S00204-015-1470-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 March 2020

1022437460

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25690730%20AND%20SRC:MED&resulttype=core&format=json